Bionano Genomics, Inc. Operating Lease, Liability, Noncurrent
Bionano Genomics, Inc. (BNGO) had Operating Lease, Liability, Noncurrent of $2.38 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-10
- 2026-06-30: Operating Lease, Liability, Noncurrent $2.38M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $2.51M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $2.49M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $2.60M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $2.38M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $2.51M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $2.49M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $2.60M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $2.70M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 |
| 2024-12-31 | $145.00K 10-K · filed 2026-03-23 |
| 2024-09-30 | $1.73M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $2.24M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $2.75M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $3.59M 10-K · filed 2025-03-31 |
| 2023-09-30 | $4.08M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $4.77M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $5.04M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $5.50M 10-K · filed 2024-03-05 |
| 2022-09-30 | $4.69M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $5.08M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $5.45M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $5.29M 10-K · filed 2023-03-09 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |